In: Pflügers Archiv - European Journal of Physiology, 2015, vol. 467, no. 12, p. 2413-2421
|
In: Journal of Molecular Cell Biology, 2016, vol. 8, no. 1, p. 62-72
|
In: Psychopharmacology, 2015, vol. 232, no. 16, p. 2981-2994
|
In: mSphere, 2018, vol. 3, no. 1, p. e00518-17
Extensive antigenic diversity within the GII.4 genotype of human norovirus is a major driver of pandemic emergence and a significant obstacle to development of cross- protective immunity after natural infection and vaccination. However, human and mouse monoclonal antibody studies indicate that, although rare, antibodies to conserved GII.4 blockade epitopes are generated. The mechanisms by...
|
In: Open forum infectious diseases, 2015, vol. 2, no. 3, p. ofv084
Background: Human noroviruses are the leading cause of acute viral gastroenteritis, justifying vaccine development despite a limited understanding of strain immunity. After genogroup I (GI).1 norovirus infection and immunization, blockade antibody titers to multiple virus-like particles (VLPs) increase, suggesting that GI cross-protection may occur. Methods: Immunoglobulin (Ig)A was purified...
|
In: Plos one, 2014, vol. 9, no. 7, p. e102658
In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally modifying the amino acid composition of its ligand binding domain. By combining sequence alignment and structural analysis of known estrogen receptor- ligand complexes with computational analysis, we were able to predict estrogen receptor mutants with altered binding properties. These predictions...
|
In: Plos pathogens, 2012, vol. 8, no. 5, p. e1002705
Noroviruses are the principal cause of epidemic gastroenteritis worldwide with GII.4 strains accounting for 80% of infections. The major capsid protein of GII.4 strains is evolving rapidly, resulting in new epidemic strains with altered antigenic potentials. To test if antigenic drift may contribute to GII.4 persistence, human memory B cells were immortalized and the resulting human monoclonal...
|
In: Lung, 2014, vol. 192, no. 6, p. 987-995
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 6, p. 1166-1171
|
In: Journal of virology, 2014, vol. 88, no. 16, p. 8826-8842
GII.4 noroviruses (NoVs) are the primary cause of epidemic viral acute gastroenteritis. One primary obstacle to successful NoV vaccination is the extensive degree of antigenic diversity among strains. The major capsid protein of GII.4 strains is evolving rapidly, resulting in the emergence of new strains with altered blockade epitopes. In addition to characterizing these evolving blockade...
|